Read More Healthcare Industry News Johnson & Johnson to purchase heart pump maker Abiomed for $16.6bn Johnson & Johnson (J&J) has agreed to acquire Abiomed, a NASDAQ-listed cardiovascular medical technology provider, in an all-cash… byRaghuram KadariNovember 2, 2022